Skip to main content


Synthetic Organic and Medicinal Chemistry

Cancer is the second leading cause of death worldwide, and treatments for cancer are constantly evolving.  Currently, although powerful, chemotherapy still suffers from side effects associated with the blocking of major biological pathways.  The Moschitto Research Group, which started in September of 2019 at Rutgers University, aims to provide additional methods for the treatment of cancers through the development of new therapeutics that combines synthetic organic chemistry, medicinal chemistry, and cancer biology.  To achieve this, we focus on the development of inhibitors that target metabolic enzymes through either irreversible or reversible means.  Additionally, we look to synthesize natural products and natural product scaffolds to obtain potent and selective therapeutics. When necessary, we will employ novel methodologies to form strategic bonds, thus improving the ease of access to important scaffolds.

The Department of Medicinal Chemistry at the Ernest Mario School of Pharmacy offers both Doctor of Philosophy (Ph.D.) and Master of Science (M.S.) degrees.  Prospective students are encouraged to apply.  More information can be found on the Medicinal Chemistry home page.

    Graduate Program   Dept of Med Chem


The sulfonylation of quinolines has been published in JOC!  Congrats Twinkle!

the group at PACSFOCS 2022

The Moschitto Group’s first paper was published in Org Lett.  Congrats Laha and Twinkle!

View More Posts